empagliflozin glp-1 The Role of GLP-1, DPP-4, and SGLT-2 Inhibitors in Diabetes Management GLP-1 Agonists in Cardiovascular Diseases:

Most people build it into their routine easily and the injection itself takes seconds

The glucagon receptor component in retatrutide likely drives the additional weight loss through increased energy expenditure and enhanced hepatic fat metabolism mechanisms not directly targeted by GLP-1 or GIP activation alone

Khavinson VKh, et al

These symptoms are not always due to ischaemic optic neuropathy and often have other explanations, but they should never be ignored or left in the hope they settle. Symptoms to Watch For Patients taking a GLP-1 medication should be alert to any sudden or unexplained change in vision